Search for: "Barr Pharmaceuticals, LLC "
Results 1 - 20
of 40
Sorted by Relevance
|
Sort by Date
11 Oct 2009, 9:04 pm
.; Barr Laboratories Inc.; Barr Pharmaceuticals Inc.; Barr Pharmaceuticals, LLC; Teva Pharmaceuticals Industries Ltd.; Teva Pharmaceuticals USA Inc. [read post]
1 Sep 2015, 9:59 pm
.; Teva Pharmaceuticals USA, Inc.; APP Pharmaceuticals, LLC; Barr Laboratories, Inc.; and Pliva Hrvatska D.O.O. sought approval to market (opinion).... [read post]
9 Oct 2009, 9:11 am
PLIVA-HRVATSKA d.o.o, PLIVA d.d., Barr Laboratories Inc., Barr Pharmaceuticals Inc., Barr Pharmaceuticals, LLC, et al. [read post]
1 Dec 2009, 9:45 am
Barr Pharmaceuticals, Inc., Barr Pharmaceuticals, LLC and Barr Laboratories Inc. [read post]
8 Oct 2016, 3:25 am
Plaintiffs, Endo Pharmaceuticals Inc. and Mallinckrodt LLC, filed these patent infringement actions against defendants Amneal Pharmaceuticals, LLC, Amneal Pharmaceuticals of New York, LLC (collectively, “Amneal”), Teva Pharmaceuticals USA, Inc. and Barr Laboratories, Inc. [read post]
7 Aug 2018, 8:20 am
Arbor Pharmaceuticals, LLC v. [read post]
8 May 2020, 6:57 pm
Eagle suedSlayback Pharma LLC for infringing four patents coveringEagle’s brand name bendamustine pharmaceutical product. [read post]
12 Aug 2011, 10:06 am
The lawsuit arose from an Abbreviated New Drug Application filed with the Food and Drug Administration that had been filed by Teva Parenteral Medicines of Israel, alleging APP Pharmaceuticals LLC of Schaumburg, Illinois, and Barr Laboratories of Montvale, New Jersey. [read post]
12 Jan 2017, 12:42 pm
.; APP Pharmaceuticals LLC; Pliva Hrvatska D.O.O. [read post]
10 Jun 2010, 3:58 am
APP Pharmaceuticals LLC et al. [read post]
19 Mar 2016, 10:13 am
Turn-Key-Tech., LLC, 381 F.3d 1142, 1154 (Fed. [read post]
1 May 2009, 9:00 am
(IAM) US: Johnson & Johnson – 5 year exclusivity period would kill incentives to innovate (Patent Docs) US: CHI CEO on patent reform and follow-on biologics legislation (Patent Docs) US: BIO urges Congress on patent reform: First, do no harm (Patent Baristas) US: Pharmaceutical advertising: How to use a domain name to circumvent application of law (Domain Name / Nom De Domaine!) [read post]
27 Aug 2012, 9:31 am
., Barr Laboratories, Inc., and APP Pharmaceuticals, LLC filed abbreviated new drug applications ("ANDAs") seeking approval to manufacture and sell generic versions of Alimta® before the expiration of the '932 patent. [read post]
27 Aug 2012, 9:31 am
., Barr Laboratories, Inc., and APP Pharmaceuticals, LLC filed abbreviated new drug applications ("ANDAs") seeking approval to manufacture and sell generic versions of Alimta® before the expiration of the '932 patent. [read post]
16 Jun 2010, 3:02 pm
Stamatios Mouratidis (TTABlog) US: Multiple rejections during prosecution undermine plaintiff’s bid for preliminary injunction: Graceway Pharmaceuticals, LLC et al v. [read post]
24 Jul 2014, 12:54 pm
District Judge Tanya Walton Pratt concluded that Defendants Teva Parenteral Medicines, Inc. of Irvine, California; APP Pharmaceuticals, LLC of Schaumburg, Illinois; Pliva Hrvatska D.O.O. of Zagreb, Croatia; Teva Pharmaceuticals USA Inc. of North Wales, Pennsylvania; and Barr Laboratories, Inc. of Montvale, New Jersey failed to prove invalidity of U.S. [read post]
27 Feb 2009, 5:00 am
USA, Inc (Orange Book Blog) (FDA Law Blog) (Patent Baristas) (Law360) (Patent Docs) (Patent Prospector) (Patently-O) (GenericsWeb) (Hal Wegner) Famvir (Famciclovir) – US: Teva loses bid to toss Novartis wilful infringement claims over Famvir (Law360) Fentora (Fentanyl) – US: Barr alleges Cima and Cephalon’s patent suit just a delay tactic (Law360) Integrilin (Eptifibatide) – US: Schering alleges patent infringement following Teva’s Para IV… [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v… [read post]
16 Nov 2007, 4:00 am
: (LawFont),BrazilBrazil pays the price for compulsory licensing: (IAM), (Generic Pharmaceuticals & IP), CanadaThe Chronicle reports that Honourable Mr. [read post]
7 Jun 2012, 8:45 am
The Wall Street Journal is also reporting that hedge fund Citadel LLC is arguing its diminished profits in the division weakened by departures to rival Jump Trading are proof that its trade secrets were stolen. [read post]
